Shares of Nicox S.A. (OTCMKTS:NICXF – Get Free Report) crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.25 and traded as low as $0.25. Nicox shares last traded at $0.25, with a volume of 500 shares trading hands.
Nicox Trading Down 10.7 %
The firm has a fifty day moving average of $0.25 and a 200 day moving average of $0.31.
About Nicox
Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.
Recommended Stories
- Five stocks we like better than Nicox
- Basic Materials Stocks Investing
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Using the MarketBeat Dividend Yield Calculator
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- ESG Stocks, What Investors Should Know
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Nicox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nicox and related companies with MarketBeat.com's FREE daily email newsletter.
